BWP
PAHC icon

Balboa Wealth Partners’s Phibro Animal Health PAHC Stock Holding History

Balboa Wealth Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
7,898
+19
+0.2% +$802 0.03% 390
2026
Q1 		$436K Buy
7,879
+1,833
+30% +$87.3K 0.07% 225
2025
Q4 		$226K Buy
6,046
+696
+13% +$28.3K 0.04% 352
2025
Q3 		$216K Buy
+5,350
New +$177K 0.04% 339

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Balboa Wealth Partners's PAHC Position: Q2 2026 in Review

Balboa Wealth Partners increased its Phibro Animal Health (PAHC) stake by 0.24% in Q2 2026, buying an estimated $802 and bringing the position to 7,898 shares worth $248K. The position accounts for 0.03% of the portfolio, ranked #390.

Balboa Wealth Partners first reported a position in PAHC in Q3 2025 and has held it in 4 quarters since. The position peaked at $436K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Balboa Wealth Partners held 7,898 shares of Phibro Animal Health worth $248K as of Q2 2026.
  • Balboa Wealth Partners bought 19 Phibro Animal Health shares in Q2 2026, an estimated $802.
  • Phibro Animal Health made up 0.03% of Balboa Wealth Partners's portfolio in Q2 2026, its #390 holding.
  • Balboa Wealth Partners first reported a position in Phibro Animal Health in Q3 2025 and has held it in 4 quarters since.
  • Balboa Wealth Partners's Phibro Animal Health position peaked at $436K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.